SemaThera
Blood & Organ Banks · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Av Du Mont-Royal O Suite 800, Montreal...Website
www.semathera.comRevenue
<$5 MillionIndustry
About SemaThera
SemaThera Inc. is focused on developing innovative treatments for diabetic and other retinal degenerative diseases, addressing the significant impact of diabetes on vision. The company has created a range of biological traps that target and neutralize semaphorin 3A and other cytokines linked to diabetic retinopathy, promoting retinal health. Their research, conducted in collaboration with leading institutions, has demonstrated the effectiveness of these traps in reducing retinal vascular leakage and inflammation. SemaThera aims to improve outcomes for patients suffering from vision impairment due to diabetes.Explore more
SIC Code 28,283NAICS Code 32,325Show moreSemaThera Org Chart
Compare Similar Companies to SemaThera
Compare insights from companies similar to SemaThera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SemaThera Tech Stack
A closer look at the technologies used by SemaThera
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding SemaThera
Sign Up For FreeTo access detailed company insights
SemaThera Inc. is focused on developing innovative treatments for diabetic and other retinal degenerative diseases, addressing the significant impact of diabetes on vision. The company has created a range of biological traps that target and neutralize semaphorin 3A and other cytokines linked to diabetic retinopathy, promoting retinal health. Their... Read More